Weight Loss for Prediabetes Using Episodic Future Thinking

Completed · Not applicable

Conditions studied: PreDiabetes

In brief

The goals of the UH3 are to assess the effectiveness of adding Episodic Future Thinking (EFT) to the investigators standard behavioral weight control program to improve weight loss, delay discounting (DD), working memory, glycemic control (HbA1c) and behavioral medication adherence over a 6 month period in persons with prediabetes and comorbid hypertension and/or hyperlipidemia. This will be accomplished by a randomized trial (N = 71 randomized) comparing the effects of EFT versus control that matches attention and use of technology.

Key facts

Study ID

NCT03670602

Run by

State University of New York at Buffalo

People needed

64

Starts

2019-01-17

Expected to finish

2021-06-30

Last updated by the study team

2022-12-09

Who can join

Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Overweight or obese (BMI ≥ 25)
• Prediabetes (HbA1c between 5.7 - 6.4%; 39-40 mmol/mol)

You may not qualify if…

• Type 2 Diabetes
• Use of diabetic drugs
• Pregnancy
• Not ambulatory
• Intellectual impairment
• Unmanaged mood disorders
• Current substance use disorder (excluding nicotine and caffeine)
• History of eating disorders (Except binge eating disorder)
• Abnormal blood glucose related to medications

Where it is running

• University at Buffalo, Department of Pediatrics, Division of Behavioral Medicine — Buffalo, New York, United States
• Fralin Biomedical Research Institute, Virginia Tech Carilion — Roanoke, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.